Moreover, another recent study revealed that patients with familial hypercholesterolemia were associated with an increased gene expression of TRAIL and a pro-inflammatory phenotype in the peripheral blood mononuclear cells, even on continuous statin treatments [23]. This evidence concerns the gene TNFSF10 and familial hypercholesterolemia.